We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Respiratory Health of Elite Athletes (cold air)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00686491
First Posted: May 29, 2008
Last Update Posted: February 23, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Laval University
  Purpose

Eleven National Sports Teams are located in the Quebec Metropolitan Area. In these groups, many athletes are aiming for Olympic medals in Beijing 2008 and Vancouver 2010 Olympic Games. A consultation of the coaches of these National Teams revealed that although a large proportion of these athletes present various cardio-respiratory symptoms, they do not have a rapid access to a systematic medical evaluation and follow-up. Furthermore, little is done in regard to prevention and optimization of treatment of pulmonary and cardiac conditions in the elite athlete's population of the Quebec area.

Cardiorespiratory problems are therefore commonly found in high-level athletes. However, these pathologies are not well characterized in athletes and the associated symptoms often not well perceived. These problems can be serious and it is important to detect them before they appear1 while setting up a systematic medical follow-up. Health professionals should monitor health of the young athletes and help to reduce the risks associated with high level exercise. The following project is an evaluation and follow-up program of high-level athletes, aiming at gathering key-information on long-term effects of high-level training on cardio-respiratory and metabolic parameters. Our aims will be

  1. to establish a long-term program of systematic evaluation and follow-up of cardiorespiratory health and performance of high elite athletes.
  2. to evaluate the prevalence of respiratory, circulatory and metabolic problems among high-level athletes
  3. to evaluate the effects of treatments on cardiorespiratory conditions and exercise performance in athletes who need asthma medication.

Condition
Asthma Cardiovascular Diseases Metabolic Diseases

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Center of Excellence in CardioRespiratory Health of High-level Athletes: Evaluation of Long-term Effects of Training.

Further study details as provided by Laval University:

Biospecimen Retention:   Samples With DNA
Serum - plasma - sputum

Enrollment: 133
Study Start Date: June 2007
Study Completion Date: December 2010
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Triathletes
2
Cold air athletes
3
Swimmers
4
Other sports elite athletes
5
Control subjects

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   14 Years to 45 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Athletes training in the province of Quebec. Controls from Quebec schools and universities.
Criteria

Inclusion Criteria:

  • Athletes training more than 10 hours per week-

Exclusion Criteria:

  • asthma or other pathologies that may interfere with the study
  • Smokers
  • Obese of with a BMI more than 29
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00686491


Locations
Canada
Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec
Quebec, Canada, G1V4G5
Sponsors and Collaborators
Laval University
Investigators
Principal Investigator: Paul POIRIER, MD Hôpital LAval
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Dr Louis-Philippe BOULET, Institut universitaire de cardiologie et de pneumologie de Québec
ClinicalTrials.gov Identifier: NCT00686491     History of Changes
Other Study ID Numbers: CER 20141
First Submitted: May 26, 2008
First Posted: May 29, 2008
Last Update Posted: February 23, 2011
Last Verified: February 2011

Keywords provided by Laval University:
Asthma
Environment
Type of sport
Cardiovascular disease
Athletes

Additional relevant MeSH terms:
Cardiovascular Diseases
Metabolic Diseases